Document Library
Click the icons below to search through Pioneer’s reports and documents.
| Filename | 340B-Drug-Discounts-WP.pdf |
| Filesize | 1 MB |
| Version | 1 |
| Date added | March 21, 2022 |
| Downloaded | 13007 times |
| Category | Health Care, Health Care Policy (Federal), Life Sciences, White Papers |
Authors: William Smith and Josh Archambault
Date: March 22, 2022
This report shows that over the past decade, the revenue for hospitals generated by the federal 340B drug discount program, initially intended to serve low-income, uninsured populations, has exploded even while a number of important Massachusetts hospitals have reduced the level of charity care they provide, and notes that nationwide, 340B drug sales rose from $9 billion in 2014 to $38 billion in 2020.